Here are relevant reports on : cell-therapy-technologies-market
-
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) & Region - Global Forecast to 2027
The global nerve repair market growth is primed to transition from $6.5 billion in 2022 to $11.6 billion by 2027, showcasing a strong CAGR of 12.1%. This growth is driven by the increasing prevalence of neurological disorders, rising geriatric population, high incidence of nerve injuries, and government support for neurological research.
- Published: May 2022
- Price: $ 4950
- TOC Available:
-
Animal Stem Cell Therapy Market by Type (Allogeneic, Autologous), Species (Dog, Cat & Horse), End User (Veterinary Hospital, Research Organization) - Global Forecast to 2027
The global animal stem cell therapy market size is projected to reach USD 0.3 billion by 2027 from USD 0.2 million in 2022, at a CAGR of 5.2% during the forecast period. The growth in the cases of various health issues such as arthritis, degenerative joint disorders, and tendon injuries in animals. This factor is encouraging the development of the global animal stem cell therapy market.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Test Type (Mycoplasma, Sterility, Endotoxin, Bioburden, Virus Safety), Application (Vaccines, mAbs, Cell & Gene Therapy, Blood Products) - Global Forecast to 2029
The global biologics safety testing market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$7.2 billion by the end of the period. Growth of the market can be attributed to factors such as the rising need for novel biotherapeutics and increasing focus on advancement of biopharmaceutical industry.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Neuroblastoma Cancer Market by Diagnostics (MIBG Scan, Imaging, Urine Analysis, Biopsy), Treatment (Surgery, Chemotherapy, Radiation therapy, Stem Cell Transplant, Immunotherapy), Staging, Pipeline, Regulatory, Reimbursement - Global Forecast to 2021
Neuroblastoma is a rare extracranial solid tumor cancer that develops from immature nerve cells found in several areas of the body. It is the most common extracranial solid tumor in childhood.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Petroleum Fuel Optimization Technologies Market - By Technologies and Geography: Trends & Forecasts to 2019
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) & Region - Global Forecasts to 2024
The cardiac resynchronization therapy market is projected to reach USD 5.1 billion by 2024, at a CAGR of 4.4%. The growth of the Cardiac Resynchronization Therapy Market is majorly driven by the increasing incidence of target diseases (primarily due to the rising geriatric population). Rising investments and support, along with technological advancements, are also contributing to the growth of this market. Prominent players in the Cardiac Resynchronization Therapy Market are Medtronic (Ireland), Abbott (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), and Medico S.p.A. (Italy).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Advanced Memory Technologies Market: PCRAM (Phase-Change), RERAM (Resistive), STTRAM (Spin Transfer Torque) By Products, Applications & Technologies - Forecast & Trend Analysis (2012-2017)
PCRAM technology, being non-volatile provides power saving opportunities to the end users. Although it is observed to possess features better than the conventional solutions such as SRAM, flash memory and DRAM, its reach in the mass markets is yet to gain momentum. While Micron Technology (HEADQUARTERS) and Samsung (Korea) lead the R&D activities with respect to PCRAM, there are also a number of other companies and universities such as Shanghai Institute of Microsystem and Information Technology of the Chinese Academy of Sciences, Microchip Technology Inc (HEAD), Semiconductor Manufacturing International Corp (HEAD) and more contribute effectively to its R&D.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Cell Viability Assays Market by Product (MTT Assay, XTT Assay, Calcein, Resazurin, Flow Cytometry, Spectrophotometer), Cell Type (Human, Animal, Microbial), Application (Basic Research, Stem Cell, Discovery & Development) - Global Forecast to 2023
The global cell viability assays market is projected to reach USD 4.16 billion by 2023, growing at a CAGR of 8.4%. The prominent players in the cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Research, Clinical, Cell Tissue & Banking), End User, Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028
The global stem cell manufacturing market, valued at US$12.0 billion in 2022, stood at US$12.7 billion in 2023 and is projected to advance at a resilient CAGR of 11.3% from 2023 to 2028, culminating in a forecasted valuation of US$21.8 billion by the end of the period. The major factors driving the growth of this market are technological advancements in stem cell manufacturing and the increasing prevalence of genetic disorders, both of which are expected to propel market growth.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029
The global cell expansion market, valued at US$12.7 billion in 2023, stood at US$14.3 billion in 2024 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth of the cell expansion market can be attributed to factors such as the booming biopharmaceutical industry, increased investments in research and development for the advancement of biopharmaceutical industry, rising need of advanced biopharmaceuticals, and increasing GMP certification for cell therapy manufacturing facilities.
- Published: March 2024
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
